肝类器官研究及应用进展

王利; 丘倚灵; 王建设

doi:10.3969/j.issn.1001-5256.2019.10.047

肝类器官研究及应用进展

DOI: 10.3969/j.issn.1001-5256.2019.10.047

1. 复旦大学附属儿科医院肝病科
2. 复旦大学附属金山医院儿科

基金项目:

国家自然科学基金面上项目(81570468,81873543)；

详细信息

中图分类号: R575
计量
- 文章访问数: 1388
- HTML全文浏览量: 63
- PDF下载量: 406
- 被引次数: 0
出版历程
- 收稿日期: 2019-05-22
- 出版日期: 2019-10-20

Advances in research and application of liver organoids

Department of Hepatology,Children's Hospital of Fudan University

Research funding:

摘要

摘要: 经典的肝脏研究模型因其无法长期维持肝细胞极性结构,或遗传代谢背景与正常人肝细胞有较大差别,对肝细胞生理功能及相关疾病机制研究存在限制。新近建立的肝类器官培养技术,可通过重编程的诱导多能干细胞或肝活检组织体外培养获得具有部分肝组织结构的肝类器官,并长期维持可扩增性和遗传稳定性,有望成为疾病建模、药物筛选及细胞治疗的有力工具。主要对肝类器官的研究现状及应用前景进行综述。
- 类器官 /
- 肝 /
- 多能干细胞
Abstract: Liver diseases significantly affect human health. Classic research models cannot maintain hepatocyte polarity for a long time and have a different genetic background from normal human hepatocytes,which limits the research on the physiological functions of hepatocytes and the mechanisms of related diseases. The latest liver organoid technology can obtain liver organoids with partial liver structure by reprogrammed induced pluripotent stem cells or in vitro culture of liver biopsy tissue and maintain long-term proliferation and genetic stability,and therefore,it is expected to become a powerful tool for disease modelling,drug screening,and cell therapy. This article mainly reviews the research and application of liver organoids in recent years.
- organoids /
- liver /
- multipotent stem cells

HTML全文

参考文献(35)

[1] ISHIBASHI H,NAKAMURA M,KOMORI A,et al. Liver architecture,cell function,and disease[J]. Semin Immunopathol,2009,31(3):399-409.

[2] ISHIBASHI H,NAKAMURA M,KOMORI A,et al. Liver architecture,cell function,and disease[J]. Semin Immunopathol,2009,31(3):399-409.

[3] HORTON R. GBD 2010:Understanding disease,injury,and risk[J]. Lancet,2012,380(9859):2053-2054.

[4] CAMP JG,SEKINE K,GERBER T,et al. Multilineage communication regulates human liver bud development from pluripotency[J]. Nature,2017,546(7659):533-538.

[5] MARIOTTI V,STRAZZABOSCO M,FABRIS L,et al. Animal models of biliary injury and altered bile acid metabolism[J].Biochim Biophys Acta Mol Basis Dis,2018,1864(4 Pt B):1254-1261.

[6] HUCH M,DORRELL C,BOJ SF,et al. In vitro expansion of single Lgr5+liver stem cells induced by Wnt-driven regeneration[J]. Nature,2013,494(7436):247-250.

[7] TAKEBE T,SEKINE K,ENOMURA M,et al. Vascularized and functional human liver from an i PSC-derived organ bud transplant[J]. Nature,2013,499(7459):481-484.

[8] DIANAT N,DUBOIS-POT-SCHNEIDER H,STEICHEN C,et al. Generation of functional cholangiocyte-like cells from human pluripotent stem cells and HepaRG cells[J]. Hepatology,2014,60(2):700-714.

[9] BROUTIER L,MASTROGIOVANNI G,VERSTEGEN MM,et al.Human primary liver cancer-derived organoid cultures for disease modeling and drug screening[J]. Nat Med,2017,23(12):1424-1435.

[10] OGAWA M,OGAWA S,BEAR CE,et al. Directed differentiation of cholangiocytes from human pluripotent stem cells[J].Nat Biotechnol,2015,33(8):853-861.

[11] SAMPAZIOTIS F,de BRITO MC,MADRIGAL P,et al. Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation[J]. Nat Biotechnol,2015,33(8):845-852.

[12] WU F,WU D,REN Y,et al. Generation of hepato-biliary organoids from human induced pluripotent stem cells[J]. J Hepatol,2019,70(6):1145-1158.

[13] HU H,GEHART H,ARTEGIANI B,et al. Long-term expansion of functional mouse and human hepatocytes as 3D organoids[J]. Cell,2018,175(6):1591-1606.

[14] NANTASANTI S,SPEE B,KRUITWAGEN HS,et al. Disease modeling and gene therapy of copper storage disease in canine hepatic organoids[J]. Stem Cell Reports,2015,5(5):895-907.

[15] KRUITWAGEN HS,OOSTERHOFF LA,VERNOOIJ I,et al.Long-term adult feline liver organoid cultures for disease modeling of hepatic steatosis[J]. Stem Cell Reports,2017,8(4):822-830.

[16] HUCH M,GEHART H,van BOXTEL R,et al. Long-term culture of genome-stable bipotent stem cells from adult human liver[J]. Cell,2015,160(1-2):299-312.

[17] SI-TAYEB K,NOTO FK,NAGAOKA M,et al. Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells[J]. Hepatology,2010,51(1):297-305.

[18] TOUBOUL T,HANNAN NR,CORBINEAU S,et al. Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development[J]. Hepatology,2010,51(5):1754-1765.

[19] SAMPAZIOTIS F,JUSTIN AW,TYSOE OC,et al. Reconstruction of the mouse extrahepatic biliary tree using primary human extrahepatic cholangiocyte organoids[J]. Nat Med,2017,23(8):954-963.

[20] GUAN Y,XU D,GARFIN PM,et al. Human hepatic organoids for the analysis of human genetic diseases[J]. JCI Insight,2017,2(17):e94954.

[21] OUCHI R,TOGO S,KIMURA M,et al. Modeling steatohepatitis in humans with pluripotent stem cell-derived organoids[J]. Cell Metab,2019,30(2):374-384,e6.

[22] LIANG G,ZHANG Y. Genetic and epigenetic variations in i PSCs:Potential causes and implications for application[J].Cell Stem Cell,2013,13(2):149-159.

[23] LORENT K,GONG W,KOO KA,et al. Identification of a plant isoflavonoid that causes biliary atresia[J]. Sci Transl Med,2015,7(286):267r-286r.

[24] BAKTASH Y,MADHAV A,COLLER KE,et al. Single particle imaging of polarized hepatoma organoids upon hepatitis C virus infection reveals an ordered and sequential entry process[J]. Cell Host Microbe,2018,23(3):382-394.

[25] NIE YZ,ZHENG YW,MIYAKAWA K,et al. Recapitulation of hepatitis B virus-host interactions in liver organoids from human induced pluripotent stem cells[J]. EBio Medicine,2018,35:114-123.

[26] CUGOLA FR,FERNANDES IR,RUSSO FB,et al. The Brazilian Zika virus strain causes birth defects in experimental models[J]. Nature,2016,534(7606):267-271.

[27] GARCEZ PP,LOIOLA EC,MADEIRO DCR,et al. Zika virus impairs growth in human neurospheres and brain organoids[J]. Science,2016,352(6287):816-818.

[28] TUVESON D,CLEVERS H. Cancer modeling meets human organoid technology[J]. Science,2019,364(6444):952-955.

[29] CAYO MA,MALLANNA SK,di FURIO F,et al. A drug screen using human i PSC-derived hepatocyte-like cells reveals cardiac glycosides as a potential treatment for hypercholesterolemia[J]. Cell Stem Cell,2017,20(4):478-489.

[30] VLACHOGIANNIS G,HEDAYAT S,VATSIOU A,et al. Patientderived organoids model treatment response of metastatic gastrointestinal cancers[J]. Science,2018,359(6378):920-926.

[31] LI M,IZPISUA BJ. Organoids-preclinical models of human disease[J]. N Engl J Med,2019,380(6):569-579.

[32] PENG WC,LOGAN CY,FISH M,et al. Inflammatory cytokine tnfalpha promotes the long-term expansion of primary hepatocytes in 3D culture[J]. Cell,2018,175(6):1607-1619.

[33] PARK SE,GEORGESCU A,HUH D. Organoids-on-achip[J]. Science,2019,364(6444):960-965.

[34] GJOREVSKI N,SACHS N,MANFRIN A,et al. Designer matrices for intestinal stem cell and organoid culture[J]. Nature,2016,539(7630):560-564.

[35] XIANG C,DU Y,MENG G,et al. Long-term functional maintenance of primary human hepatocytes in vitro[J]. Science,2019,364(6438):399-402.

施引文献

资源附件(0)

访问统计